NPT
AZN icon

Nixon Peabody Trust’s AstraZeneca AZN Stock Holding History

Nixon Peabody Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8M Buy
+42,186
New +$7.93M 0.57% 51
2026
Q1 		– Sell
-38,797
Closed -$7.13M – 165
2025
Q4 		$7.13M Buy
38,797
+22
+0.1% +$3.86K 0.54% 55
2025
Q3 		$5.95M Buy
38,775
+564
+1% +$85.4K 0.44% 60
2025
Q2 		$5.34M Buy
38,211
+712
+2% +$99.8K 0.41% 62
2025
Q1 		$5.51M Buy
+37,499
New +$5.43M 0.47% 57

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Nixon Peabody Trust's AZN Position: Q2 2026 in Review

Nixon Peabody Trust opened a new position in AstraZeneca (AZN) in Q2 2026: 42,186 shares worth $8M. The stake represents 0.57% of the portfolio and ranks #51 among its holdings. This is a return to the name: Nixon Peabody Trust previously reported a position in AZN as recently as Q4 2025.

Nixon Peabody Trust first reported a position in AZN in Q1 2025 and has held it in 5 quarters since. 534 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Nixon Peabody Trust held 42,186 shares of AstraZeneca worth $8M as of Q2 2026.
  • AstraZeneca was a new Nixon Peabody Trust position in Q2 2026.
  • AstraZeneca made up 0.57% of Nixon Peabody Trust's portfolio in Q2 2026, its #51 holding.
  • Nixon Peabody Trust first reported a position in AstraZeneca in Q1 2025 and has held it in 5 quarters since.
  • 534 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.